The decrease in tumor size from miR-31 inhibition coincided with the reduction in Ki67+ and Cyclin D1+ proliferating cells (Figure 7B and Figure 7—figure supplement 1B), and correlated with reduced Wnt activity and increased BMP and TGFβ activities (Figure 7—figure supplement 1B). The gene discussed is CCND1; the disease is neoplasm.